LPA and Stroke: Over a median follow-up period of 50 months, the results indicated that, compared to the persistently low Lp(a) group, the persistently high Lp(a) group had significantly increased risks of major adverse cardiovascular and cerebrovascular events (MACCE), nonfatal stroke, unplanned revascularization, all-cause mortality, and cardiovascular mortality.